Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

COVID-19 Vaccine Janssen suspension for injection {equilateral_black_triangle}

Active Ingredient:
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)
Company:  
Janssen-Cilag Ltd See contact details
ATC code: 
J07BN02
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 27 Sep 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

Janssen-Cilag Ltd
Company image
Address
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone
+44 (0)1494 567 567
Fax
+44 (0)1494 567 568
Medical Information Direct Line
+44 (0)800 731 8450
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)800 731 5550
Medical Information Fax
+44 (0) 1494 567 445